To the Point Eyetube

Jennifer Shaba, OD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on the latest episode to share her story about opening her own dry eye practice focused on regenerative medicine and holistic eye care. Dr. Shaba offers advice for optometrists at the very beginning of their own journey in dry eye.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, are joined by retina specialist Srinivas Kondapalli, MD, who developed the Rinsada Irrigating Lid Retractor, which effectively cleanses the conjunctival fornix, palpebral conjunctiva, and bulbar conjunctiva.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, catch up with Crystal M. Brimer, OD, FAAO, to talk about her prolific journey in dry eye. Dr. Brimer discusses opening her own practice, creating the Dry Eye Institute to promote education among eye care providers, and shares tips to help other ODs to get started or revitalize their dry eye services.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, welcome this month’s guest, Ada Noh, OD. Dr. Noh shares her story of how she came to open her very own practice, dedicated solely to dry eye, in a brand new city. She talks about building up her patient base, networking with local providers, and lessons she learned along the way.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, interview Keylee Brown, OD, to learn how she came to offer radio frequency therapy in her dry eye clinic. Dr. Brown talks about how the technology works with intense pulsed light, how she educates patients about it, fits it into her workflow, and the rewarding clinical results she has witnessed since purchasing the device.

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, kick off 2024 with a conversation about several new and anticipated products for treating ocular surface disease, including cyclosporine ophthalmic solution 0.1% (Vevye, Harrow), perfluorohexyloctane ophthalmic solution (Meibo, Bausch + Lomb), and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals). They also share some practice pearls and professional goals for the year ahead.